Please ensure Javascript is enabled for purposes of website accessibility

3 Winning Cannabis Stocks You Can Buy for Less Than $50

By Keith Speights - Jun 4, 2021 at 5:55AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Each of them has nearly tripled or more over the last 12 months and could deliver even greater returns over the long term.

Some stock prices are too high for many investors. That's unfortunate because there are quite a few great stocks with lofty share prices.

There's good news, though, if you're interested in profiting from the fast-growing cannabis industry. The share prices of most cannabis companies are affordable for nearly any investor's budget. Some of these inexpensive pot stocks also offer tremendous growth prospects and strong track records. Here are three winning cannabis stocks you can buy for less than $50.

Cannabis buds next to three $50 bills.

Image source: Getty Images.

Green Thumb Industries

You can buy a share of Green Thumb Industries (GTBIF 2.50%) right now for around $30. The stock is up more than 20% year to date and has nearly tripled over the last 12 months.

Green Thumb's solid stock performance reflects the underlying strength of its business. The company sells cannabis products in 12 states with retail stores in 11 of those markets. In the first quarter of 2020, Green Thumb's revenue soared 89.5% year over year to $194.4 million. It posted a third consecutive quarter of positive net income and a fifth consecutive quarter of positive cash flow. 

The company already operates in several of the top recreational cannabis markets in the U.S., including California, Illinois, Nevada, and New Jersey. New York's legalization of recreational marijuana opens up a new growth opportunity. In addition, Green Thumb has operations in key medical cannabis markets, such as Florida, Ohio, and Pennsylvania.

We'll soon be able to add Virginia to the list. Green Thumb expects to close its acquisition of Dharma Pharmaceuticals in the second half of 2021. The deal will give it one of five vertical licenses in the state's medical cannabis market. Buying Dharma could also put Green Thumb in a good position to succeed in Virginia's recreational market, which opens in 2024.  

Jushi Holdings

Fifty dollars will go a long way if you want to invest in Jushi Holdings (JUSHF -0.53%). The stock currently trades below $6. So far this year, Jushi hasn't delivered a sizzling return with shares barely in positive territory. Over the last 12 months, though, the marijuana stock has almost quintupled. Jushi could also be a stock that could make you rich over the long term.

The company reported revenue of $41.7 million in the first quarter of 2021, up 29% from the previous quarter. Jushi isn't profitable yet. However, it generated positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 of $3 million.

Jushi's acquisitions should continue to fuel growth. In recent months, the company has bought a dispensary in California and 78% of the equity of another California retail license holder. It's acquired a Nevada cannabis operator. Jushi has also announced pending acquisitions of a Massachusetts cannabis operator and an Ohio medical cannabis cultivator. 

Like Green Thumb, Jushi is poised to win in the Virginia market as well. The company holds a license to serve the potentially lucrative medical cannabis market in northern Virginia, home to almost 30% of the state's population.

Trulieve Cannabis

You aren't limited to just up-and-coming cannabis stocks like Jushi with a $50 budget, though. One share of Trulieve Cannabis (TCNNF 1.23%) will set you back less than $40. Trulieve stock has jumped more than 20% year to date and has more than tripled over the last 12 months.

Trulieve ranks as the 800-pound gorilla in Florida's medical cannabis market. The company operates 82 dispensaries in the Sunshine State and claims a market share of nearly 50%. 

In addition to Florida, Trulieve currently operates in four other states -- California, Connecticut, Pennsylvania, and Massachusetts. It also received approval to operate in West Virginia.

The biggest story for Trulieve going forward, though, is its pending acquisition of Harvest Health & Recreation. This deal will give Trulieve a presence in 11 states. The combination of the two companies will create the largest and most profitable U.S. multistate operator. 

Keith Speights has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Green Thumb Industries, Jushi Holdings, and Trulieve Cannabis Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Trulieve Cannabis Stock Quote
Trulieve Cannabis
$13.15 (1.23%) $0.16
Green Thumb Industries Stock Quote
Green Thumb Industries
$11.09 (2.50%) $0.27
Harvest Health & Recreation Inc. Stock Quote
Harvest Health & Recreation Inc.
Jushi Holdings Inc. Stock Quote
Jushi Holdings Inc.
$1.89 (-0.53%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/12/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.